To hear about similar clinical trials, please enter your email below
Trial Title:
Piloting a Virtual Navigation (VN) System for Bronchoscopic Lung Nodule Sampling
NCT ID:
NCT05599321
Condition:
Lung Cancer
Conditions: Keywords:
bronchoscopy
computer-assisted surgery
image-guided surgery
surgical navigation
image-guided biopsy
multimodal imaging
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Diagnostic Test
Intervention name:
Virtual Navigation System
Description:
The Virtual Navigator guidance computer is interfaced to the bronchoscopy hardware to tap
off the live bronchoscopy and EBUS video feeds. The standard OR medical team
(technicians, clinical fellows, et al.) is on hand, and standard clinical facilities
(e.g., fluoroscopy, CT/PET image viewer) are available. Our technical team is also
present to record all procedural video and computer display information. It also operates
the guidance computer during the guided procedure and offers any assistance in case of
unanticipated issues. The participant's clinical bronchoscopy will be recorded by the
radiology imaging management system.
Arm group label:
Consented Clinical Bronchoscopy Cohort
Summary:
The overall goal is to evaluate the role of a Virtual Navigation (VN) system (the Virtual
Navigator) in the bronchoscopic evaluation and tissue sampling of lung cancer and other
chest lesions at the Penn State Hershey Medical Center (HMC). The Virtual Navigator is a
software package that runs on a mobile Windows-based computer. The computer takes in up
to four clinical image/video sources, ordered by the clinician for clinical purposes: 1)
3D CT (computed tomography) imaging scan; 2) 3D PET (positron emission tomography)
imaging scan (optional); 3) Bronchoscopic video of the airway tree interior; 4)
Ultrasound video of scanned anatomy outside the airways, as provided by an endobronchial
ultrasound (EBUS) probe (optional). During a live guided procedure, the Virtual Navigator
presents images that assist with navigating the bronchoscope to predesignated chest
lesions.
Lung cancer patients that present a suspicious peripheral tumor on their chest CT scan
are often prescribed to undergo a diagnosis-and-staging bronchoscopy, whereby the
bronchoscopist examines both the suspect tumor and any identified central-chest lymph
nodes. For the clinical study, we consider bronchoscopy performance for two cohorts: 1) a
cohort of consented patients who undergo image-guided bronchoscopy via the Virtual
Navigator; and 2) a historical controls cohort consisting of patients who underwent
bronchoscopy recently at our medical center (state-of-the-art bronchoscopy practice). The
study's general hypothesis is that an image-guided bronchoscopy system (the Virtual
Navigator) that integrates 3D imaging, bronchoscopy, and EBUS images enables more
complete evaluation and sampling of chest lesions than current state-of-the-art clinical
techniques. More specifically, for peripheral-tumor diagnosis, the sub-hypothesis is that
the VN system increases diagnostic biopsy yield as compared to state-of-the-art
bronchoscopy practice; for central-chest nodal staging, the sub-hypothesis is that the VN
system enables the sampling of more lymph nodes than state-of-the-art bronchoscopy
practice.
Criteria for eligibility:
Study pop:
The subject population includes patients whose clinical evaluation requires a diagnostic
bronchoscopy for evaluation of parenchymal or mediastinal abnormalities. This patient
population is typically 40-70 years old.
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- patients from age 18 and over
- a planned clinical bronchoscopy to evaluate abnormal lung parenchyma and/or central
chest lymph nodes
- a clinical CT scan performed at Hershey Medical Center that meets technical
specifications and is available on the Radiology research server
- (Optional, use if available) CT/PET images that meet technical specifications and
are available on the Hershey Medical Center clinical image storage system
Exclusion Criteria:
- inability to give consent
- the CT scan does not meet technical specifications
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Penn State Milton S. Hershey Medical Center
Address:
City:
Hershey
Zip:
17033
Country:
United States
Status:
Recruiting
Contact:
Last name:
Timothy P Sheehan, MS
Phone:
717-531-2925
Email:
tsheehan@pennstatehealth.psu.edu
Investigator:
Last name:
Rebecca Bascom, MD
Email:
Sub-Investigator
Start date:
June 16, 2023
Completion date:
October 2025
Lead sponsor:
Agency:
Penn State University
Agency class:
Other
Collaborator:
Agency:
Milton S. Hershey Medical Center
Agency class:
Other
Source:
Penn State University
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05599321